Time domain X-ray luminescence computed tomography: numerical simulations.

Biomed Opt Express

Department of Bioengineering, University of California, Merced, Merced, CA 95343, USA.

Published: January 2019

X-ray luminescence computed tomography (XLCT) has the potential to image the biodistribution of nanoparticles inside deep tissues. In XLCT, X-ray excitable nanophosphors emit optical photons for tomographic imaging. The lifetime of the nanophosphor signal, rather than its intensity, could be used to extract biological microenvironment information such as oxygenation in deep tumors. In this study, we propose the design, the forward model, and the reconstruction algorithm of a time domain XLCT for lifetime imaging with high spatial resolution. We have investigated the feasibility of the proposed design with numerical simulations. We found that the reconstructed lifetime images are robust to noise levels up to 5% and to unknown optical properties up to 4 times of absorption and scattering coefficients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363188PMC
http://dx.doi.org/10.1364/BOE.10.000372DOI Listing

Publication Analysis

Top Keywords

time domain
8
x-ray luminescence
8
luminescence computed
8
computed tomography
8
numerical simulations
8
domain x-ray
4
tomography numerical
4
simulations x-ray
4
tomography xlct
4
xlct potential
4

Similar Publications

Background: Small, soluble oligomers, rather than mature fibrils, are the major neurotoxic agents in Alzheimer's disease (AD). In the last few years, Aprile and co-workers designed and purified a single-domain antibody (sdAb), called DesAb-O, with high specificity for Aβ oligomeric conformers. Recently, Cascella and co-workers showed that DesAb-O can selectively detect synthetic Aβ oligomers both in vitro and in cultured cells, neutralizing their associated neuronal dysfunction.

View Article and Find Full Text PDF

Background: Hypertension is a risk factor for cognitive impairment and dementia. Anti-hypertensives (AHT) are commonly used in old age, but their association with cognition and brain pathology is not well understood.

Method: To investigate the relation of AHT with change in cognitive function and postmortem brain pathology, we evaluated 4,207 older persons without known dementia at enrollment and a subset of 1880 participants who died and came to autopsy.

View Article and Find Full Text PDF

Background: Loneliness has been linked to cognitive decline and an elevated risk of Alzheimer's disease (AD). Previous studies measured loneliness at a single point time, which may not accurately capture the longitudinal changes of different loneliness types (e.g.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Pentara, Salt Lake CIty, UT, USA.

Background: Clinical assessments utilized in trials to measure progression in sporadic Alzheimer's disease (SAD) such as the MMSE, ADAS-Cog, CDR-SB and ADCS-ADL are well established. Distinct assessments are utilized for Down Syndrome-related Alzheimer's disease (DSAD). Although these assessments are less well established, they probe comparable domains of cognition and function.

View Article and Find Full Text PDF

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

Johns Hopkins Global Neurology, University Teaching Hospital, Lusaka, Lusaka, Zambia.

Background: Globally, 47.5 million people were living with dementia in 2015. This figure is expected to reach 75.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!